Charles Richard Bradshaw

Charles Richard Bradshaw

Auto-generated profile, based on publicly available information

Charles Richard Bradshaw

Wellcome Trust / CRUK Gurdon Institute, University of Cambridge, Cambridge, UK

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2012 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
RRRaphaël Rodriguez
Raphaël Rodriguez
KMKyle Miller
Kyle Miller
JFJosep V Forment
Josep V Forment
CBCharles R Bradshaw
Charles R Bradshaw
MNMehran Nikan
Mehran Nikan
SJStephen P Jackson
Stephen P Jackson
Identifying DNA sequences that adopt alternative structures within the context of genomic DNA presents a major challenge. Pyridostatin, a G-quadruplex–specific chemical probe, was shown to induce DNA damage at specific genomic sites, including the proto-oncogene SRC, leading to cell cycle arrest in human cancer cells. Guanine-rich DNA sequences that can adopt non–Watson-Crick structures in vitro are prevalent in the human genome. Whether such structures normally exist in mammalian cells has, however, been the subject of active research for decades. Here we show that the G-quadruplex–interacting drug pyridostatin promotes growth arrest in human cancer cells by inducing replication- and transcription-dependent DNA damage. A chromatin immunoprecipitation sequencing analysis of the DNA damage marker γH2AX provided the genome-wide distribution of pyridostatin-induced sites of damage and revealed that pyridostatin targets gene bodies containing clusters of sequences with a propensity for G-quadruplex formation. As a result, pyridostatin modulated the expression of these genes, including the proto-oncogene SRC. We observed that pyridostatin reduced SRC protein abundance and SRC-dependent cellular motility in human breast cancer cells, validating SRC as a target of this drug. Our unbiased approach to define genomic sites of action for a drug establishes a framework for discovering functional DNA-drug interactions.

1 June 2015 in Cell
Verified
Journal Article
Open access
WTWalfred W.C. Tang
Walfred W.C. Tang
SDSabine Dietmann
Sabine Dietmann
NINaoko Irie
Naoko Irie
HLHarry G. Leitch
Harry G. Leitch
VFVasileios I. Floros
Vasileios I. Floros
MSM. Azim Surani
M. Azim Surani
Resetting of the epigenome in human primordial germ cells (hPGCs) is critical for development. We show that the transcriptional program of hPGCs is distinct from that in mice, with co-expression of somatic specifiers and naive pluripotency genes TFCP2L1 and KLF4. This unique gene regulatory network, established by SOX17 and BLIMP1, drives comprehensive germline DNA demethylation by repressing DNA methylation pathways and activating TET-mediated hydroxymethylation. Base-resolution methylome analysis reveals progressive DNA demethylation to basal levels in week 5-7 in vivo hPGCs. Concurrently, hPGCs undergo chromatin reorganization, X reactivation, and imprint erasure. Despite global hypomethylation, evolutionarily young and potentially hazardous retroelements, like SVA, remain methylated. Remarkably, some loci associated with metabolic and neurological disorders are also resistant to DNA demethylation, revealing potential for transgenerational epigenetic inheritance that may have phenotypic consequences. We provide comprehensive insight on early human germline transcriptional network and epigenetic reprogramming that subsequently impacts human development and disease.

28 February 2010 in Nature
Verified
Journal Article
Closed access
PDF file
CCClaudio Collinet
Claudio Collinet
MSMartin Stöter
Martin Stöter
CBCharles R. Bradshaw
Charles R. Bradshaw
NSNikolay Samusik
Nikolay Samusik
JRJochen C. Rink
Jochen C. Rink
MZMarino Zerial
Marino Zerial

28 March 2011 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
JHJeanine A. Harrigan
Jeanine A. Harrigan
RBRimma Belotserkovskaya
Rimma Belotserkovskaya
JCJulia Coates
Julia Coates
DDDaniela S. Dimitrova
Daniela S. Dimitrova
SPSophie Polo
Sophie Polo
SJStephen P. Jackson
Stephen P. Jackson
Chromosomal deletions and rearrangements in tumors are often associated with common fragile sites, which are specific genomic loci prone to gaps and breaks in metaphase chromosomes. Common fragile sites appear to arise through incomplete DNA replication because they are induced after partial replication inhibition by agents such as aphidicolin. Here, we show that in G1 cells, large nuclear bodies arise that contain p53 binding protein 1 (53BP1), phosphorylated H2AX (γH2AX), and mediator of DNA damage checkpoint 1 (MDC1), as well as components of previously characterized OPT (Oct-1, PTF, transcription) domains. Notably, we find that incubating cells with low aphidicolin doses increases the incidence and number of 53BP1-OPT domains in G1 cells, and by chromatin immunoprecipitation and massively parallel sequencing analysis of γH2AX, we demonstrate that OPT domains are enriched at common fragile sites. These findings invoke a model wherein incomplete DNA synthesis during S phase leads to a DNA damage response and formation of 53BP1-OPT domains in the subsequent G1.

23 August 2013 in Science
Verified
Journal Article
Closed access
PDF file
CCClara Collart
Clara Collart
GAGeorge E. Allen
George E. Allen
CBCharles R. Bradshaw
Charles R. Bradshaw
JSJames C. Smith
James C. Smith
PZPhilip Zegerman
Philip Zegerman
Regulating the MBT: It has been known for more than 30 years that a defined number of cell divisions in the frog embryo precede a crucial developmental event called the midblastula transition (MBT). Collart et al. (p. 893 , published online 1 August) now elucidate a mechanism involved in the control of the MBT. DNA replication initiation factors are titrated out during early cell divisions, which controls the elongation of the cell cycle and the onset of zygotic transcription during the MBT.

25 April 2016 in Nature Communications
Verified
Journal Article
Open access
LWLaura Wagstaff
Laura Wagstaff
MGMaja Goschorska
Maja Goschorska
KKKasia Kozyrska
Kasia Kozyrska
GDGuillaume Duclos
Guillaume Duclos
IKIwo Kucinski
Iwo Kucinski
EPEugenia Piddini
Eugenia Piddini
Cell competition is a quality control mechanism that eliminates unfit cells. How cells compete is poorly understood, but it is generally accepted that molecular exchange between cells signals elimination of unfit cells. Here we report an orthogonal mechanism of cell competition, whereby cells compete through mechanical insults. We show that MDCK cells silenced for the polarity gene scribble (scribKD) are hypersensitive to compaction, that interaction with wild-type cells causes their compaction and that crowding is sufficient for scribKD cell elimination. Importantly, we show that elevation of the tumour suppressor p53 is necessary and sufficient for crowding hypersensitivity. Compaction, via activation of Rho-associated kinase (ROCK) and the stress kinase p38, leads to further p53 elevation, causing cell death. Thus, in addition to molecules, cells use mechanical means to compete. Given the involvement of p53, compaction hypersensitivity may be widespread among damaged cells and offers an additional route to eliminate unfit cells.